RWA
LUNG icon

Redhawk Wealth Advisors’s Pulmonx LUNG Stock Holding History

Redhawk Wealth Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
99,648
+64,948
+187% +$89.5K 0.01% 406
2026
Q1 		$44.8K Buy
+34,700
New +$57.3K ﹤0.01% 384

Other funds holding LUNG

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Redhawk Wealth Advisors's LUNG Position: Q2 2026 in Review

Redhawk Wealth Advisors increased its Pulmonx (LUNG) stake by 187% in Q2 2026, buying an estimated $89.5K and bringing the position to 99,648 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #406.

Redhawk Wealth Advisors first reported a position in LUNG in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Redhawk Wealth Advisors held 99,648 shares of Pulmonx worth $130K as of Q2 2026.
  • Redhawk Wealth Advisors bought 64,948 Pulmonx shares in Q2 2026, an estimated $89.5K.
  • Pulmonx made up 0.01% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #406 holding.
  • Redhawk Wealth Advisors first reported a position in Pulmonx in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.